Logo: University of Southern California

USC Viterbi Professors Named AIMBE Fellows

Terry Sanger and Jim Weiland are elected to the prestigious American Institute for Medical and Biological Engineering
By: Marc Ballon
March 23, 2015 —

AIMBE Fellows Terence Sanger and James Weiland
USC Viterbi Professors Terence Sanger and James Weiland have been elected fellows of the American Institute for Medical and Biological Engineering (AIMBE), a designation conferred on only the top 2 percent of medical and biological engineers in the country.

"In being inducted to the 2015 Class of Fellows, Terry Sanger and Jim Weiland join a distinguished group of around 1,500 other fellows from academia, industry and government who have made contributions to bioengineering research, industrial practice and education that have transformed the world,” said Michael Khoo, interim chair of the Department of Biomedical Engineering. Khoo attended the March 16 AIMBE induction ceremony in Washington D.C.

Sanger, a provost associate professor of biomedical engineering, neurology and biokinesiology, was elected for outstanding contributions to mathematical modeling and quantitative understanding of brain disorders in children. His research could one day contribute to children with cerebral palsy, dystonia and other movement disorders regaining control of their bodies with the help of artificial spinal chords, controllable prosthetics and exoskeletons.

Weiland, a professor of biomedical engineering and ophthalmology, was inducted for his research on electronic retinal prosthesis for the blind and bioelectric implant technology — Weiland was a leader and key researcher on the Retinal Prosthesis project, which contributed to the Argus 2 project, the world's first commercially available visual prosthetic aid for the blind. In 2013, he and USC Viterbi’s Ellis Meng and Malancha Gupta received a prestigious $2-million grant from the National Science Foundation for a joint research project on a wireless, multi-sensor system for the early detection of shunt malfunctions in people with excessive brain fluid.

AIMBE, founded in 1991, advocates for medical and biological engineering for the benefit of the general public.